PMID
              27552618
          abstract
              In this preliminary study, RNA biosignatures were defined to distinguish febrile infants aged 60 days or younger with vs without bacterial infections. Further research with larger populations is needed to refine and validate the estimates of test accuracy and to assess the clinical utility of RNA biosignatures in practice.
          status
              available
          journal
              JAMA
          manuscript url
              
          In Dashboard
              No